PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,736,774 | -4.3% | 100,160 | 0.0% | 1.12% | -0.9% |
| Q2 2023 | $1,814,899 | -31.9% | 100,160 | 0.0% | 1.13% | -33.7% |
| Q1 2023 | $2,664,256 | +25.1% | 100,160 | -9.1% | 1.70% | +12.0% |
| Q4 2022 | $2,129,393 | -7.5% | 110,160 | 0.0% | 1.52% | -20.2% |
| Q3 2022 | $2,301,000 | +139.2% | 110,160 | -8.3% | 1.90% | +126.3% |
| Q2 2022 | $962,000 | +14.3% | 120,160 | 0.0% | 0.84% | +25.0% |
| Q1 2022 | $842,000 | -48.1% | 120,160 | 0.0% | 0.67% | -44.7% |
| Q4 2021 | $1,622,000 | -20.0% | 120,160 | 0.0% | 1.22% | -27.8% |
| Q3 2021 | $2,028,000 | -42.0% | 120,160 | 0.0% | 1.68% | -41.6% |
| Q2 2021 | $3,499,000 | – | 120,160 | – | 2.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |